Salveen Richter - The Goldman Sachs Group Analyst Performance This page shows the methodology used to calculate Salveen Richter's recommendation performance. Listed below are links to the research notes issued, the price targets issued by the analyst, and the stock's actual price 12 months from the date the research note was issued. These rankings are based on research reports from . Rankings are updated daily. MarketBeat Analyst Ranking: Subscribe to MarketBeat All Access for the recommendation accuracy ratingAverage 12-Month ROI of Buy and Strong Buy Recommendations: ???% Export to Excel CompanyReport DateReport Date Price12-MonthPrice TargetRating12-MonthActual Price12-MonthROIDetailsFDMT4D Molecular Therapeutics8/12/2025$6.17$38.00Buy???%???%SRPTSarepta Therapeutics8/7/2025$17.42$19.00Neutral???%???%ACADACADIA Pharmaceuticals8/7/2025$23.89$17.00Sell???%???%SRPTSarepta Therapeutics6/17/2025$22.03$29.00Hold???%???%ELVNEnliven Therapeutics6/16/2025$21.91$37.00Buy???%???%FDMT4D Molecular Therapeutics5/9/2025$3.06$44.00Buy???%???%RCUSArcus Biosciences5/8/2025$8.14$13.00Neutral???%???%CRSPCRISPR Therapeutics5/8/2025$35.40$47.00Neutral???%???%SRPTSarepta Therapeutics5/7/2025$37.52$100.00Buy???%???%BMRNBioMarin Pharmaceutical5/5/2025$62.48$104.00Buy???%???%FOLDAmicus Therapeutics5/2/2025$6.56$9.00Neutral???%???%REGNRegeneron Pharmaceuticals4/30/2025$590.09$804.00Buy???%???%BIIBBiogen4/23/2025$120.33$197.00Buy???%???%REGNRegeneron Pharmaceuticals4/14/2025$560.49$917.00Buy???%???%ADPTAdaptive Biotechnologies3/21/2025$7.75$9.00Buy???%???%SMMTSummit Therapeutics2/28/2025$18.49$42.00Buy???%???%CRSPCRISPR Therapeutics2/13/2025$42.93$57.00Neutral???%???%BIIBBiogen2/13/2025$136.88$245.00Buy???%???%GILDGilead Sciences2/12/2025$103.52$96.00Neutral???%???%MRNAModerna1/29/2025$44.94$51.00Neutral???%???%MRNAModerna1/28/2025$43.47$99.00Buy???%???%DNLIDenali Therapeutics1/28/2025$22.99$40.00Buy???%???%ADPTAdaptive Biotechnologies1/28/2025$7.76$7.50Neutral???%???%NTLAIntellia Therapeutics1/14/2025$10.05$12.00Neutral???%???%BLUEbluebird bio1/3/2022$10.60Conviction-Buy???%???%BLUEbluebird bio11/8/2021$262.80$200.00Sell???%???%SGENSeagen2/11/2020$116.51$165.00Buy???%???%SRPTSarepta Therapeutics12/24/2019$134.30$180.00Buy???%???%CLLSCellectis8/12/2019$12.20$20.00Hold???%???%BLUEbluebird bio10/15/2016$1,131.40$2,700.00Buy???%???%BLUEbluebird bio9/15/2016$1,257.80$2,700.00Conviction-Buy???%???%BLUEbluebird bio9/8/2016$1,056.20$2,700.00Buy???%???%BLUEbluebird bio8/18/2016$1,134.00$2,700.00Buy???%???%BMRNBioMarin Pharmaceutical6/1/2016$87.42$126.00Buy???%???%ICPTIntercept Pharmaceuticals5/31/2016$141.77$128.00Neutral???%???%AVXSAveXis5/13/2016$35.16$47.00Buy???%???%MDVN(MDVN)5/1/2016$57.80$44.00Neutral???%???%BLUEbluebird bio4/23/2016$1,006.40$2,980.00Neutral???%???%BLUEbluebird bio4/11/2016$1,016.40$2,980.00Buy???%???%SAGESage Therapeutics4/1/2016$32.06$63.00Buy???%???%BMRNBioMarin Pharmaceutical3/7/2016$86.67$129.00Conviction-Buy???%???%BLUEbluebird bio2/22/2016$1,041.00$2,980.00???%???%JUNOJuno Therapeutics2/22/2016$35.62$41.00???%???%KITE(KITE)2/22/2016$48.13$92.00???%???%GEVA(GEVA)2/27/2015$99.42$125.00Buy???%???%RAREUltragenyx Pharmaceutical2/11/2015$53.65$62.00Buy???%???%GEVA(GEVA)1/8/2015$104.02Buy???%???%RAREUltragenyx Pharmaceutical1/8/2015$48.65Buy???%???% Return to Analyst Rankings Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access